Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company iCell Gene Therapeutics
DescriptionChimeric antigen receptor engineered T-cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today